First German medical cannabis company to provide a sustainable, sun-grown and chemical-pesticide free product line

Our CEO, Pia Marten, spoke with Krautinvest about Cannovum’s unique place on the German market as the first medical cannabis company to employ this sustainable approach to their own product line.

Read More
Download pdf

Mehr News

July 2022

Cannovum AG part of the International Expert Hearings on Cannabis Legalization

Cannovum AG has participated in the consultation process of the German government for the legalization of cannabis for Adult-use.

April 2022

Cannovum AG resolves capital increase from authorized capital excluding subscription rights

The Management Board of Cannovum AG today resolved to increase the share capital.

February 2022

Cannovum AG launches Cannabis Medical Education Platform

Cannovum Medical Education (CME) is a free, comprehensive virtual continuing education platform for medical cannabis, in which the medical-therapeutic basics of medical cannabis are scientifically prepared.